Silver diamine Fluoride 38%
Silver diamine Fluoride 38% is a pharmaceutical drug with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Traditional vs. Minimally Invasive Decay Treatments in Primary Molars: An 18-month Split-mouth Randomized Study
Building Adaptive School-based Interventions for Caries
SDF vs Fluoride Varnish for Streptococcus Mutans Reduction in Children
Pilot and Feasibility Study of Impact of SDF 38% Application on Oral Health of Elderly With Autonomy Loss
SDF Application in Oral Cancer Patients to Prevent Dental Caries
Clinical Trials (10)
Traditional vs. Minimally Invasive Decay Treatments in Primary Molars: An 18-month Split-mouth Randomized Study
Building Adaptive School-based Interventions for Caries
SDF vs Fluoride Varnish for Streptococcus Mutans Reduction in Children
Pilot and Feasibility Study of Impact of SDF 38% Application on Oral Health of Elderly With Autonomy Loss
SDF Application in Oral Cancer Patients to Prevent Dental Caries
Effect of Silver Diamine Fluoride Application on Oral Microbiome of Healthy Pediatric Patient
Silver Diamine Fluoride Modified Restoration In Treating Hypomineralized First Permanent Molar.
Silver Diamine Fluoride Pilot Study (SDF)
Comparison of Silver Modified and Conventional Atraumatic Restorative Treatment Modalities
Silver Diamine Fluoride Treatment of Active Root Caries Lesions in Older Adults: A Case Series
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10